title: Assessing pain objectively: the use of physiological markers.
abstract: Pain diagnosis and management would benefit from the development of objective markers of nociception and pain. Current research addressing this issue has focused on five main strategies, each with its own advantages and disadvantages. These encompass: (i) monitoring changes in the autonomic nervous system; (ii) biopotentials; (iii) neuroimaging; (iv) biological (bio-) markers; and (v) composite algorithms. Although each strategy has shown areas of promise, there are currently no validated objective markers of nociception or pain that can be recommended for clinical use. This article introduces the most important developments in the field and highlights shortcomings, with the aim of allowing the reader to make informed decisions about what trends to watch in the future.
authors.affiliation: Chelsea and Westminster NHS Foundation Trust, Faculty of Medicine, Imperial College London, Chelsea and Westminster Hospital Campus, London, UK.
authors.forename: R
authors.initials: R
authors.lastname: Cowen
authors.affiliation: National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.
authors.forename: M K
authors.initials: MK
authors.lastname: Stasiowska
authors.affiliation: Chelsea and Westminster NHS Foundation Trust, Faculty of Medicine, Imperial College London, Chelsea and Westminster Hospital Campus, London, UK.
authors.forename: H
authors.initials: H
authors.lastname: Laycock
authors.affiliation: Chelsea and Westminster NHS Foundation Trust, Faculty of Medicine, Imperial College London, Chelsea and Westminster Hospital Campus, London, UK.
authors.forename: C
authors.initials: C
authors.lastname: Bantel
mesh_terms: D000465:Algorithms; D015415:Biomarkers; D004562:Electrocardiography; D004569:Electroencephalography; D004576:Electromyography; D006801:Humans; D059906:Neuroimaging; D010146:Pain / Q000175:diagnosis*
chemical_list: D015415:Biomarkers